Effective induction of oestrogen suppression2
Prostap DCS provided significant suppression of serum 17β-oestradiol at 12 and 24 weeks compared with baseline2
Adapted from Crosignani PG et al, 1996.2
If you are a healthcare professional and have a clinical query about Prostap DCS, please call Medical Information on:01628 537 900 DSO-UK@takeda.com
If you would like to find out more about how Prostap DCS can help your practice save money, or to order, please call CLARITYpharma on:0845 080 5190 firstname.lastname@example.org
If you are a healthcare professional and would like to be contacted about Prostap DCS, please enter your details in the short form below
Takeda UK Ltd will NOT share any of your details with any other parties. If at any time you wish to unsubscribe from receiving information about Prostap DCS, please call Takeda UK Ltd on 01628 537 900.